TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 1 | 1 | 0 | -7 | -7 | -36 | -17 | -13 |
| P | %wins | 100 | 100 | 0 | 0 | 0 | 0 | 33 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/16/16 16:11 | 3/9/16 | LPTN | Lpath, Inc | DE | Health | BioPrd | Biological Products, (No Diag | Swortwood Donald | CA | D | M.d | 0 | 0.00 | 0 | 3 | 0 | 770 | D | -96 | -94 | -5 | -9 | 31 | 11 | 17 | 17 | 5 | -5 | 24 | -22 | -2 | ||
4/23/15 20:02 | 4/22/15 | LPTN | Lpath, Inc | DE | Health | BioPrd | Biological Products, (No Diag | Swortwood Donald | CA | D | M.d | 0 | 0.00 | 0 | 6 | 1 | 767 | D | -55 | -50 | -24 | -23 | -25 | -3 | -6 | 0 | 0 | -4 | -86 | -87 | -90 | -89 | |
2/12/14 18:59 | 2/10/14 | LPTN | Lpath, Inc | NV | Health | BioPrd | Biological Products, (No Diag | Swortwood Donald | CA | D | M.d | 0 | 0.00 | 0 | 3 | 0 | 761 | I | -37 | -9 | -24 | -13 | 4 | -12 | -5 | 5 | 0 | 4 | 8 | -7 | -20 | -33 | |
8/15/08 16:13 | 8/12/08 | LPTN | Lpath, Inc | NV | Health | BioPrd | Biological Products, (No Diag | Swortwood Donald | CA | D | P.d | 125 | 0.9500 | 0 | 132 | 3 | 5,376 | D | -22 | -32 | -11 | 19 | 17 | 22 | 8 | 1 | 0 | -7 | -7 | -36 | -17 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |